<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0"><channel><title>Yahoo! Finance: HEB News</title><copyright>Copyright (c) 2009 Yahoo! Inc. All rights reserved.</copyright><link>http://finance.yahoo.com/q/h?s=heb</link><description>Latest Financial News for HEMISPHERX BIOPHARMA</description><language>en-us</language><lastBuildDate>Fri, 18 Dec 2009 12:00:00 Etc/GMT</lastBuildDate><image><url>http://us.news2.yimg.com/us.yimg.com/p/fi/pr/40197.gif</url><title>Yahoo! Finance</title><link>http://finance.yahoo.com</link><width>144</width><height>17</height></image><item><title>Biotech Stock Mailbag: Year in Review (at TheStreet.com)</title><link>http://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=12uv4f7ja/*http%3A//www.thestreet.com/_yahoo/story/10647632/1/biotech-stock-mailbag-year-in-review.html?cm_ven=YAHOO&amp;cm_cat=FREE&amp;cm_ite=NA</link><description></description><guid isPermaLink="false">yahoo_finance/537529219</guid><pubDate>Fri, 18 Dec 2009 12:00:00 Etc/GMT</pubDate></item><item><title>Hemispherx Biopharma Addresses Ampligen(R) Manufacturing Issues (GlobeNewswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091216/180474.html?.v=1</link><description>PHILADELPHIA -- Hemispherx Biopharma, Inc. , stated that on December 11, 2009, the Company, via its manufacturing subcontractor, in Spokane, WA, submitted comprehensive new data to the regional office of the Food and Drug Administration , Seattle, WA, which Hemispherx management believes demonstrate that certain manufacturing issues noted in earlier pre-approval inspections at the facility have been fully addressed.</description><guid isPermaLink="false">yahoo_finance/3043698161</guid><pubDate>Wed, 16 Dec 2009 21:56:55 Etc/GMT</pubDate></item><item><title>Brower Piven Announces the Filing of a Class Action Lawsuit Against Hemispherx Biopharma, Inc. Expanding the Class Period to Include February 18, 2009 Through December 1, 2009, and Encourages Investors Who Have Losses in Excess of $100,000 (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/091211/0568299.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/3337578909</guid><pubDate>Fri, 11 Dec 2009 21:09:00 Etc/GMT</pubDate></item><item><title>Berger &amp; Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug (PR Newswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091210/dc24436.html?.v=1</link><description>The law firm of Berger &amp; Montague, P.C. has filed a class action in the U.S. District Court for the Eastern District of Pennsylvania that expands the proposed class period to include all purchasers of Hemispherx Biopharma, Inc. securities between February 18, 2009 and December 1, 2009, inclusive .</description><guid isPermaLink="false">yahoo_finance/3388840468</guid><pubDate>Thu, 10 Dec 2009 19:09:00 Etc/GMT</pubDate></item><item><title>Skymark Research Initiates Independent Research Coverage on Hemispherx Biopharma, Inc. (GlobeNewswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091210/179996.html?.v=1</link><description>CALGARY, Alberta -- Skymark Research, a leading provider of small- and micro-cap independent investment research, today initiated coverage on Hemispherx Biopharma, Inc. . Skymark Research is currently offering a complimentary trial subscription.</description><guid isPermaLink="false">yahoo_finance/585261138</guid><pubDate>Thu, 10 Dec 2009 14:00:00 Etc/GMT</pubDate></item><item><title>Securities Class Action Filed by Shepherd, Finkelman, Miller &amp; Shah, LLP on Behalf of Hemispherx Biopharma Securities Purchasers Between February 18, 2009 and November 2, 2009 (PR Newswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091208/dc22886.html?.v=1</link><description>Shepherd, Finkelman, Miller &amp; Shah, LLP , a law firm with offices in California, Connecticut, Florida, New Jersey, Pennsylvania and Wisconsin, has filed a lawsuit seeking class action status in the United States District Court for the Eastern District of Pennsylvania against Hemispherx Biopharma, Inc. and the Company&apos;s CEO, William A.</description><guid isPermaLink="false">yahoo_finance/796486840</guid><pubDate>Tue, 8 Dec 2009 21:00:00 Etc/GMT</pubDate></item><item><title>Ariad, Cephalon Make ASH Splash: BioBuzz (at TheStreet.com)</title><link>http://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=1306rp4bm/*http%3A//www.thestreet.com/_yahoo/story/10640902/1/ariad-cephalon-make-ash-splash-biobuzz.html?cm_ven=YAHOO&amp;cm_cat=FREE&amp;cm_ite=NA</link><description></description><guid isPermaLink="false">yahoo_finance/1461373</guid><pubDate>Tue, 8 Dec 2009 15:45:35 Etc/GMT</pubDate></item><item><title>Hemispherx CEO Buys After Stock Collapse: BioBuzz (at TheStreet.com)</title><link>http://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=13a9ebg6g/*http%3A//www.thestreet.com/_yahoo/story/10640765/1/hemispherx-ceo-buys-after-stock-collapse-biobuzz.html?cm_ven=YAHOO&amp;cm_cat=FREE&amp;cm_ite=NA</link><description></description><guid isPermaLink="false">yahoo_finance/781397221</guid><pubDate>Tue, 8 Dec 2009 14:56:47 Etc/GMT</pubDate></item><item><title>Slowing Swine Bursts BioCryst Bubble: BioBuzz (at TheStreet.com)</title><link>http://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=136r6368a/*http%3A//www.thestreet.com/_yahoo/story/10640676/1/slowing-swine-bursts-biocryst-bubble-biobuzz.html?cm_ven=YAHOO&amp;cm_cat=FREE&amp;cm_ite=NA</link><description></description><guid isPermaLink="false">yahoo_finance/2359717687</guid><pubDate>Tue, 8 Dec 2009 14:11:49 Etc/GMT</pubDate></item><item><title>Federman &amp; Sherwood Announces That a Securities Class Action Lawsuit Has Been Filed Against Hemispherx Biopharma, Inc. (AMEX: HEB) (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/091204/0565923.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/1311485708</guid><pubDate>Fri, 4 Dec 2009 21:27:00 Etc/GMT</pubDate></item><item><title>Hemispherx Upbeat Despite FDA setback (at TheStreet.com)</title><link>http://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=12vsdn394/*http%3A//www.thestreet.com/_yahoo/story/10638718/1/hemispherx-upbeat-despite-fda-setback.html?cm_ven=YAHOO&amp;cm_cat=FREE&amp;cm_ite=NA</link><description></description><guid isPermaLink="false">yahoo_finance/95791590</guid><pubDate>Fri, 4 Dec 2009 14:30:02 Etc/GMT</pubDate></item><item><title>Hemispherx Needs to Face Reality (at TheStreet.com)</title><link>http://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=12qhjdv5e/*http%3A//www.thestreet.com/_yahoo/story/10638718/1/hemispherx-needs-to-face-reality.html?cm_ven=YAHOO&amp;cm_cat=FREE&amp;cm_ite=NA</link><description></description><guid isPermaLink="false">yahoo_finance/1870267874</guid><pubDate>Fri, 4 Dec 2009 14:30:02 Etc/GMT</pubDate></item><item><title>Biotech Stock Mailbag: Hemispherx Biopharma (at TheStreet.com)</title><link>http://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=134lk0p58/*http%3A//www.thestreet.com/_yahoo/story/10638338/1/biotech-stock-mailbag-hemispherx-biopharma.html?cm_ven=YAHOO&amp;cm_cat=FREE&amp;cm_ite=NA</link><description></description><guid isPermaLink="false">yahoo_finance/83810379</guid><pubDate>Fri, 4 Dec 2009 12:00:00 Etc/GMT</pubDate></item><item><title>[$$] BioFuel Energy Soars 34%; DRDGold Shines (at The Wall Street Journal Online)</title><link>http://us.rd.yahoo.com/finance/external/wsj/rss/SIG=12i4cd6ej/*http%3A//online.wsj.com/article/SB10001424052748703735004574572281261553644.html?ru=yahoo&amp;mod=yahoo_hs</link><description></description><guid isPermaLink="false">yahoo_finance/73677151</guid><pubDate>Thu, 3 Dec 2009 01:30:38 Etc/GMT</pubDate></item><item><title>Equities Update: Flat Finish as Energies Weigh (at Seeking Alpha)</title><link>http://us.rd.yahoo.com/finance/external/pssa/rss/SIG=12oeia7dh/*http%3A//seekingalpha.com/article/176241-equities-update-flat-finish-as-energies-weigh?source=yahoo</link><description></description><guid isPermaLink="false">yahoo_finance/1319120414</guid><pubDate>Wed, 2 Dec 2009 21:31:53 Etc/GMT</pubDate></item><item><title>Geron, StemCells: Late Day Volume Plays (at TheStreet.com)</title><link>http://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=12voocgig/*http%3A//www.thestreet.com/_yahoo/story/10637120/1/geron-stemcells-late-day-volume-plays.html?cm_ven=YAHOO&amp;cm_cat=FREE&amp;cm_ite=NA</link><description></description><guid isPermaLink="false">yahoo_finance/1097052206</guid><pubDate>Wed, 2 Dec 2009 20:04:05 Etc/GMT</pubDate></item><item><title>Rosen Law Firm Announces Class Action Lawsuit Against Hemispherx Biopharma, Inc. (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/091202/0565053.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/1204435550</guid><pubDate>Wed, 2 Dec 2009 17:21:00 Etc/GMT</pubDate></item><item><title>Biotech Stocks: Dyax, Santarus, CytRx soar; Hemispherx craters (at MarketWatch)</title><link>http://us.rd.yahoo.com/finance/external/cbsm/rss/SIG=12og2mge7/*http%3A//www.marketwatch.com/news/story/dyax-santarus-cytrx-soar-hemispherx/story.aspx?guid=%7BF00AAFBE%2D8CA9%2D4683%2DA193%2D024E82B43CA3%7D&amp;siteid=yhoof</link><description>Dyax&apos;s shares gain on news the biotech company has won regulatory approval for its drug to treat the rare disorder hereditary angioedema.</description><guid isPermaLink="false">yahoo_finance/139779039</guid><pubDate>Wed, 2 Dec 2009 16:38:00 Etc/GMT</pubDate></item><item><title>FDA rejects Hemispherx’s chronic fatigue drug Ampligen (at bizjournals.com)</title><link>http://us.rd.yahoo.com/finance/external/bizj/rss/SIG=12kp7nrdu/*http%3A//philadelphia.bizjournals.com/philadelphia/stories/2009/11/30/daily23.html?ana=yfcpc</link><description></description><guid isPermaLink="false">yahoo_finance/525443711</guid><pubDate>Wed, 2 Dec 2009 16:05:18 Etc/GMT</pubDate></item><item><title>Biotech Stocks: Dyax rockets, Hemispherx craters on FDA updates (at MarketWatch)</title><link>http://us.rd.yahoo.com/finance/external/cbsm/rss/SIG=12ouo2nkf/*http%3A//www.marketwatch.com/news/story/dyax-rockets-hemispherx-craters-fda/story.aspx?guid=%7BF00AAFBE%2D8CA9%2D4683%2DA193%2D024E82B43CA3%7D&amp;siteid=yhoof</link><description></description><guid isPermaLink="false">yahoo_finance/2733770889</guid><pubDate>Wed, 2 Dec 2009 15:26:00 Etc/GMT</pubDate></item></channel></rss><!-- c16.finance.sp2.yahoo.com compressed/chunked Tue Dec 22 07:21:57 PST 2009 -->
